Tag: NASDAQ:DRRX

Business

DURECT Corporation (NASDAQ:DRRX): 20% Potential Upside As POSIDUR Enters Final Phase

Brandon Manns -
Health

DURECT Corporation (NASDAQ:DRRX) Still Recovering From FDA Turn Down

Rebecca Harrison -
Health

DURECT Corporation (NASDAQ:DRRX) Ties UP With Impax Laboratories Inc (NASDAQ:IPXL)

Aaron Lyons -
© Copyright 2018 - Financials Trend